Our site uses cookies to improve the contents of the site and customize it according to individual use. Please confirm that you agree to our use of cookies by clicking Yes.

If you continue without explicit consent, we will assume that you agree to our cookie policy.

MEDISOA comprehensive portal site for
Medical Innovation Support Office (MEDISO).Medical Innovation Support Office

厚生労働省

Knowledgeable experts support the practical application of medicines, medical devices, and regenerative medicinal products.

2021.07.30「ジャパン・ヘルスケアベンチャー・サミット2021」出展者の応募期限を令和3年8月6日(金)まで延長いたします

NEWS

「ジャパン・ヘルスケアベンチャーサミット2021」の出展者を募集いたします。

2021.07.15【広報】経済産業省_ジャパン・ヘルスケアビジネスコンテスト(JHeC)2022 応募受付開始のご案内<締め切り:2021年8月20日(金)正午>

NEWS

経済産業省より、「ジャパン・ヘルスケアビジネスコンテスト(JHeC)2022」の開催決定と応募受付開始のご案内がありました。

2021.07.20MEDISOインタビュー記事 株式会社リボルナバイオサイエンス様

NEWS

MEDISO相談企業である株式会社リボルナバイオサイエンス様がBiogenと中枢神経疾患領域における医薬品の共同研究開発ならびにオプション付ライセンス契約を締結されたことを発表されました。

2021.07.08【広報】JETRO_医療機器オンライン商談会2021(ASEAN・中国・南西アジア)のご案内<締め切り:7月26日(月)>

NEWS

ジェトロより、医療機器オンライン商談会2021(ASEAN・中国・南西アジア)のご案内がありました。

お知らせをもっと見る

What is MEDISO

MEDISO provides support for business ventures, academia,
and individuals intending to put into practical use medicines,
medical devices, and regenerative medicinal products.
Click here for further details.

About the Medical Innovation Support Office

The medical innovation support office matches medical venture companies and academic institutions facing challenges in the practical application of medical products and devices for specialists* who provide detailed consultation and support for solving problems at each stage from research and development to practical use, as well as insurance coverage at clinical sites, while looking ahead to the overall comprehensive advances and dissemination into the global market.
* Specialists in each field provide support for the response to laws and regulations, marketing, business planning, fund rasing, management strategy, intellectual property management, and international development, etc.

This website is operated by Mitsubishi Research Institute, Inc., as a trustee under instructions from the Economic Affairs Division, Health Policy Bureau, and Ministry of Health, Labour and Welfare as a part of the total support for the medical ventures program sponsored by the Ministry of Health, Labour and Welfare.

Support targets

Ventures, academic institutions, and individuals aiming to put into practical use the medicines, medical devices, regenerative medicinal products, and novel drug-discovery technologies or medical materials subject to the Pharmaceuticals and Medical Devices Law.

Details of support

MEDISO provides support for the practical application of medicines, medical devices, regenerative medicinal products, and other products subject to the Pharmaceuticals and Medical Devices Law.
That support includes business planning, financing, advice on laws and regulations, and other assistance as required.

Click here for inquiries and consultation requests

Specialists Introduction

We will introduce registered specialists
(updated as necessary).

Masahiro Kanamaru

Beyond Next Ventures Inc.

Main specialty areas

  • medical devices

Specialized support fields

  • Regulatory compliance
  • Marketing
  • Business planning
  • Funding
  • Business operation systems
  • Specialized support fields

He graduated with a master's degree in physics from the Department of Physics, Graduate School of Science, Tohoku University, and received his MBA from the Graduate School of Management, GLOBIS University. At Toshiba Corporation, he led the research and development of the next generation optical disc at the R&D center, as well as HDD planning, development, and manufacturing for cloud servers. After that, he engaged in investment in technical startups at DBJ Capital Co., Ltd. He participated in Beyond Next Ventures Co., Ltd., in 2016. He is conducting investment and business support mainly in medical devices and the technology fields. He concurrently served as a project promoter of the Program for Creating New Industry from Universities by the Japan Science and Technology Agency.

Nobutaka Tani

Coordinator for Collaboration Between Industry and Academia, “Compass to Healthy Life” Research Complex program of the Institute of Physical and Chemical Research

Main specialty areas

  • medical devices
  • regenerative medicine products

Specialized support fields

  • Regulatory compliance
  • Marketing
  • Business planning
  • Funding
  • Business operation systems
  • Specialized support fields

He graduated with a master’s degree from the Department of Synthetic Chemistry, Graduate School of Engineering, University of Tokyo. He led the research and development and the launching new project for medical devices, including blood purification system and brain and heart catheters, at Kaneka Corporation. After that, he was involved in RD of the whole life science, including biopharmaceuticals, as the head of the Life Science RD Center, while investing in medical venture companies such as DDS and establishing joint ventures. He then moved to JSR Corporation and established JSR Life Sciences. He led the launch of the life science project for M&A as the first president since JSR Life Sciences was established. As a part of open innovation, he established a CVC and invested in or acquired venture companies in Japan and overseas, while successively holding the positions of president of the invested companies.

Daisuke Sugiyama

Hiroshima University, Translational Research Center, Professor

Main specialty areas

  • medicines
  • medical devices
  • regenerative medicine products

Specialized support fields

  • Regulatory compliance
  • Funding
  • Business operation systems
  • Specialized support fields

He graduated with a doctoral degree in medicine from the Graduate School of Medicine, University of Tokyo. After working for a hospital as a clinician, he studied under a scholarship for studying in France from the French government and worked as an Overseas Research Fellow of the Japan Society for the Promotion of Science. After that and since 2006, he had worked for Kyushu University. Since 2012, he has been at the Center for Clinical and Translational Research (CCTR) of Kyushu University Hospital, where he has promoted translational research projects of identifying and fostering drug seeds and collaboration among industry, government, and academia. Making use of his experience in serving as a TLO advisor and starting a business, he is also fostering BIO entrepreneurships.

Kazuhiro Kanmuri

Inter-Professional Inc.

Main specialty areas

  • medicines
  • regenerative medicine products

Specialized support fields

  • Regulatory compliance
  • Marketing
  • Business operation systems

He engaged in pharmaceutical research and development for more than 20 years. Over the past few years, he has gained experience in Japan and in the US development organization of Daiichi Sankyo Co., Ltd., and Pfizer Inc., and has been deeply involved in strategic planning of clinical development, including overseas and overall work. His specialized fields are wide, which include company clinical trials and investigator-initiated clinical trials, organization management, strategy construction, and clinical trial operation, and he is active in the academic area of regulatory science. Currently, he engages in the consulting business as an expert in clinical development/organization and human resources development through the corporation that he established by himself. In addition to being the incumbent, he concurrently served as a visiting lecturer of an academia organization, and he belongs to DIA Japan, an industry association of the pharmaceutical industry, and served as the Vice Program Committee Chair of the DIA Japan annual convention this year.

Shunichi Takahashi

Bayer Yakuhin, Ltd.

Main specialty areas

  • medicines
  • regenerative medicine products

Specialized support fields

  • Marketing
  • Business planning
  • Funding
  • Business operation systems

After joining Mitsui Pharmaceuticals Co., Ltd., he worked at Nihon Schering K.K., Berlex Biosciences (a US subsidiary of Schering AG). In 2007, he joined Bayer due to management integration. Over the past 15 years, he was in charge of exploring new projects and verifying concepts in drug discovery research, especially in the areas of cardiovascular systems, immunity, stem cell research, etc. Subsequently, he was in charge of the project management cardiovascular system area manager of development headquarters, the primary care manager of the medical affairs headquarters, and he has been in his current role since 2014 (Open Innovation Center director). He leads strategic partnerships and joint research with Japanese academies and venture companies. He is also verifying new pharmaceutical business models that take advantage of big data, AI, IoT, and others. In 2018, he launched the first venture incubation facility (CoLaboraotor Kobe) as a foreign-affiliated pharmaceutical company and is focusing on fostering ecosystems.

About details of specialists

Introduction of measures implemented by public institutions

We will describe the measures from public institutions for pharmaceutical companies,
medical device companies, companies manufacturing regenerative medicinal products, and venture companies.

See more about measures implemented by public institutions